| For: | Takeuchi M, Takino JI, Sakasai-Sakai A, Takata T, Ueda T, Tsutsumi M, Hyogo H, Yamagishi SI. Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies. World J Hepatol 2014; 6(12): 880-893 [PMID: 25544875 DOI: 10.4254/wjh.v6.i12.880] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v6/i12/880.htm |
| Number | Citing Articles |
| 1 |
Eva Gatineau, Sergio Polakof, Dominique Dardevet, Laurent Mosoni. Similarities and interactions between the ageing process and high chronic intake of added sugars. Nutrition Research Reviews 2017; 30(2) doi: 10.1017/S0954422417000051
|
| 2 |
Jun-ichi Takino, Takuma Sato, Takumi Kanetaka, Kasumi Okihara, Kentaro Nagamine, Masayoshi Takeuchi, Takamitsu Hori. RasGRP2 inhibits glyceraldehyde-derived toxic advanced glycation end-products from inducing permeability in vascular endothelial cells. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-82619-0
|
| 3 |
Ethan J. Anderson, Giulio Vistoli, Lalage A. Katunga, Katsuhiko Funai, Luca Regazzoni, T. Blake Monroe, Ettore Gilardoni, Luca Cannizzaro, Mara Colzani, Danilo De Maddis, Giuseppe Rossoni, Renato Canevotti, Stefania Gagliardi, Marina Carini, Giancarlo Aldini. A carnosine analog mitigates metabolic disorders of obesity by reducing carbonyl stress. Journal of Clinical Investigation 2018; 128(12) doi: 10.1172/JCI94307
|
| 4 |
Masayoshi Takeuchi. Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related Diseases. Diagnostics 2016; 6(2) doi: 10.3390/diagnostics6020023
|
| 5 |
Xin Sun, Yan Zhang, Meilin Xie. The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease. Acta Pharmaceutica 2017; 67(1) doi: 10.1515/acph-2017-0007
|
| 6 |
Maria F. Fernandes, Juan J. Aristizabal-Henao, Phillip M. Marvyn, Iman M'Hiri, Meghan A. Wiens, Monica Hoang, Manuel Sebastian, Renato Nachbar, Philippe St-Pierre, Kalsha Diaguarachchige De Silva, Geoffrey A. Wood, Jamie W. Joseph, Christine A. Doucette, André Marette, Ken D. Stark, Robin E. Duncan. Renal tubule-specific Atgl deletion links kidney lipid metabolism to glucagon-like peptide 1 and insulin secretion independent of renal inflammation or lipotoxicity. Molecular Metabolism 2024; 81 doi: 10.1016/j.molmet.2024.101887
|
| 7 |
Amedeo Lonardo, Fabio Nascimbeni, Alessandro Mantovani, Giovanni Targher. Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?. Journal of Hepatology 2018; 68(2) doi: 10.1016/j.jhep.2017.09.021
|
| 8 |
Yu Bai, Zhili Tian, Yin Li, Xinjian Guo, Hui Gao, Yitao Liu, Jun Ma, Fanrong Liu. Qinggan Jiangzhi Cha ameliorates NAFLD by modulating the AGE-RAGE/PRKCA/MAPK3/AP-1 signaling axis. Journal of Ethnopharmacology 2026; 368 doi: 10.1016/j.jep.2026.121783
|
| 9 |
Jingjing Cai, Meng Xu, Xiaojing Zhang, Hongliang Li. Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases. Annual Review of Pathology: Mechanisms of Disease 2019; 14(1) doi: 10.1146/annurev-pathmechdis-012418-013003
|
| 10 |
Rohini Mehta, Gladys Shaw, Peter Masschelin, Sean Felix, Munkzhul Otgonsuren, Ancha Baranova, Zachary Goodman, Zobair Younossi, Barry I. Hudson. Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH). PLOS ONE 2018; 13(6) doi: 10.1371/journal.pone.0199294
|
| 11 |
Atsushi Iwamura, Masahito Ito, Hideaki Mitsui, Jun Hasegawa, Keigo Kosaka, Ichiro Kino, Minoru Tsuda, Miki Nakajima, Tsuyoshi Yokoi, Toshiyuki Kume. Toxicological evaluation of acyl glucuronides utilizing half-lives, peptide adducts, and immunostimulation assays. Toxicology in Vitro 2015; 30(1) doi: 10.1016/j.tiv.2015.10.013
|
| 12 |
Mohd W. A. Khan, Ahmed A. Otaibi, Arwa F. M. Alhumaid, Abdulmohsen K. D. Alsukaibi, Asma K. Alshamari, Eida M. Alshammari, Salma A. Al-Zahrani, Ahmed Y. M. Almudyani, Subuhi Sherwani. Garlic Extract: Inhibition of Biochemical and Biophysical Changes in Glycated HSA. Applied Sciences 2021; 11(22) doi: 10.3390/app112211028
|
| 13 |
Kathleen Priken, Gladys Tapia, Cynthia Cadagan, Nicolás Quezada, Javiera Torres, Amanda D'Espessailles, Paulina Pettinelli. Higher hepatic advanced glycation end products and liver damage markers are associated with nonalcoholic steatohepatitis. Nutrition Research 2022; 104 doi: 10.1016/j.nutres.2022.04.005
|
| 14 |
Mona M. Allam, Walaa B. El gazzar. Exendin-4, a glucagon-like peptide-1 receptor agonist downregulates hepatic receptor for advanced glycation end products in non-alcoholic steatohepatitis rat model. Archives of Physiology and Biochemistry 2018; 124(1) doi: 10.1080/13813455.2017.1348362
|
| 15 |
Akiko Sakasai-Sakai, Kenji Takeda, Masayoshi Takeuchi. Involvement of Intracellular TAGE and the TAGE–RAGE–ROS Axis in the Onset and Progression of NAFLD/NASH. Antioxidants 2023; 12(3) doi: 10.3390/antiox12030748
|
| 16 |
Masayoshi Takeuchi. Toxic AGEs (TAGE) theory: a new concept for preventing the development of diseases related to lifestyle. Diabetology & Metabolic Syndrome 2020; 12(1) doi: 10.1186/s13098-020-00614-3
|
| 17 |
Keiko Wada, Yuma Nakashima, Michiyo Yamakawa, Akihiro Hori, Mitsuru Seishima, Shinobu Tanabashi, Shogen Matsushita, Naoki Tokimitsu, Chisato Nagata. Dietary advanced glycation end products and cancer risk in Japan: From the Takayama study. Cancer Science 2022; 113(8) doi: 10.1111/cas.15455
|
| 18 |
Masayoshi Takeuchi, Jun-ichi Takino, Akiko Sakasai-Sakai, Takanobu Takata, Mikihiro Tsutsumi. Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD. Nutrients 2017; 9(6) doi: 10.3390/nu9060634
|
| 19 |
Mona M. Allam, Reham M. Ibrahim, Walaa Bayoumie El Gazzar, Mona A. Said. Dipeptedyl peptidase-4 (DPP-4) inhibitor downregulates HMGB1/TLR4/NF-κB signaling pathway in a diabetic rat model of non-alcoholic fatty liver disease. Archives of Physiology and Biochemistry 2024; 130(1) doi: 10.1080/13813455.2021.1975758
|
| 20 |
Takanobu Takata, Akiko Sakasai-Sakai, Tadashi Ueda, Masayoshi Takeuchi. Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-39202-5
|
| 21 |
Jun-ichi Takino, Kentaro Nagamine, Takamitsu Hori, Akiko Sakasai-Sakai, Masayoshi Takeuchi. Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma. World Journal of Hepatology 2015; 7(23): 2459-2469 doi: 10.4254/wjh.v7.i23.2459
|
| 22 |
Wei Wang, Zhixi Chen, Tiansheng Zheng, Ming Zhang. Xanthohumol Alleviates T2DM-induced Liver Steatosis and Fibrosis by Mediating the NRF2/RAGE/NF-κB Signaling Pathway. Future Medicinal Chemistry 2021; 13(23) doi: 10.4155/fmc-2021-0241
|
| 23 |
Masayoshi Takeuchi, Akiko Sakasai-Sakai, Takanobu Takata, Jun-ichi Takino, Yoshiki Koriyama, Chigusa Kikuchi, Ayako Furukawa, Kentaro Nagamine, Takamitsu Hori, Tamihide Matsunaga. Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage. Biomolecules 2021; 11(3) doi: 10.3390/biom11030387
|
| 24 |
UEG Week 2016 Poster Presentations. United European Gastroenterology Journal 2016; 4(5_suppl) doi: 10.1177/2050640616663689
|
| 25 |
Noha F. Hassan, Somaia A. Nada, Azza Hassan, Mona R. El-Ansary, Muhammad Y. Al-Shorbagy, Rania M. Abdelsalam. Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic Steatohepatitis. Inflammation 2019; 42(3) doi: 10.1007/s10753-019-00967-6
|
| 26 |
Takanobu Takata, Akiko Sakasai-Sakai, Jun-ichi Takino, Masayoshi Takeuchi. Evidence for Toxic Advanced Glycation End-Products Generated in the Normal Rat Liver. Nutrients 2019; 11(7) doi: 10.3390/nu11071612
|